Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | acetylcholinesterase | 0.0158 | 1 | 1 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Loa Loa (eye worm) | carboxylesterase | 0.0158 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0027 | 0.1095 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0027 | 0.1095 | 0.1095 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0027 | 0.1095 | 0.5 |
Onchocerca volvulus | 0.0027 | 0.1095 | 1 | |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0158 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0027 | 0.1095 | 0.1095 |
Echinococcus granulosus | carboxylesterase 5A | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0158 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0027 | 0.1095 | 0.1095 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 1 | 1 |
Schistosoma mansoni | acetylcholinesterase | 0.0027 | 0.1095 | 0.1095 |
Brugia malayi | Carboxylesterase family protein | 0.0027 | 0.1095 | 0.1095 |
Onchocerca volvulus | 0.0027 | 0.1095 | 1 | |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0027 | 0.1095 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Echinococcus granulosus | neuroligin | 0.0027 | 0.1095 | 0.1095 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0027 | 0.1095 | 0.1095 |
Brugia malayi | Carboxylesterase family protein | 0.0027 | 0.1095 | 0.1095 |
Onchocerca volvulus | 0.0027 | 0.1095 | 1 | |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Schistosoma mansoni | gliotactin | 0.0027 | 0.1095 | 0.1095 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Brugia malayi | Carboxylesterase family protein | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Brugia malayi | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Echinococcus multilocularis | neuroligin | 0.0027 | 0.1095 | 0.1095 |
Brugia malayi | Carboxylesterase family protein | 0.0027 | 0.1095 | 0.1095 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0027 | 0.1095 | 0.5 |
Onchocerca volvulus | 0.0027 | 0.1095 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Onchocerca volvulus | 0.0027 | 0.1095 | 1 | |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0027 | 0.1095 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1095 | 0.1095 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0027 | 0.1095 | 0.1095 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0027 | 0.1095 | 0.1095 |
Loa Loa (eye worm) | carboxylesterase | 0.0027 | 0.1095 | 0.1095 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0027 | 0.1095 | 0.5 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0027 | 0.1095 | 0.1095 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.